Resource Library

This policy outlines the guidelines for delegating authority within a business entity to ensure efficient operations while maintaining fiscal and policy integrity.

This Wisdom of the Crowd, compiled from questions and responses posted on the IT, Privacy and eCommerce eGroup, addresses the legal concerns that arise when taking photographs of employees and non-employees at company events, to be used for marketing and other promotional purposes by the organization in the United States.

Learn about privacy rights and information protection provided by South Africa's Protection of Personal Information Act 4.

Learn about recent cybersecurity and data protection legislation in China and related security assessments, certification or standard contracts, and restrictions.

Learn about the Mauritian Data Protection Act 2017 provisions on data transfer and portability as compared with GDPR.

Learn about the recent Security Assessment Measures in China and their provisions for three approaches to cross-border transfers of personal information.

The Personalized Medicine Coalition (PMC) recently released its annual report on the progress of precision medicine as measured by precision medicine FDA approvals in 2022 (“Report”). As summarized in the Report, 2022 milestones include progress in diagnostics, therapeutics and new treatment modalities that are covered in this resource from Foley and Lardner LLP.

With the pandemic, there came a digital health explosion, with companies working swiftly to bring new technologies to light that would pave the way forward in telehealth and other critical areas. We saw an incredible interest in this space then, but what is the state of digital health now? This resource from Foley & Lardner LLP looks at data from public and private financing markets in the digital health space in 2022, and look forward to what to expect in 2023.

With the health care industry under pressure to improve patient outcomes while controlling costs, artificial intelligence (AI) and machine learning (ML) are quickly becoming indispensable tools. These technologies show promise in supporting decision-making, enhancing the delivery of care, and personalizing medicine. This resource from Foley & Lardner explores opportunities for health care organizations deploying AI-based solutions.

This resource provided by Foley & Lardner LLP covers the DOJ’s announcement on February 6th of their withdrawal of the 2011 Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings Program (2011 ACO Statement) in addition to two other health care antitrust policy statements.